| Name | Section 182: Microbiome Metabolomics and SCFA Therapy in CBS/PSP |
| Summary | Comprehensive coverage of short-chain fatty acid (SCFA) therapy for CBS/PSP patients, including butyrate, propionate, and acetate supplementation, microbiome-derived metabolite replacement strategies, personalized probiotics to enhance endogenous SCFA production, clinical implementation protocols, e |